About SHATOD 'Dr. Marko Antonov Markov'-Varna, EOOD
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
3
Pfizer
3
Incyte Corporation
2
Boehringer Ingelheim
1
Clinical Trials at SHATOD 'Dr. Marko Antonov Markov'-Varna, EOOD
During the past decade, SHATOD 'Dr. Marko Antonov Markov'-Varna, EOOD conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 6 clinical trials were completed, i.e. on
average, 120% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
An Investigational Drug, PF-02341066, Is Being Studied In Patients With Advanced Non-Small Cell Lung Cancer With A Specific Gene Profile Involving The Anaplastic Lymphoma Kinase (ALK) Gene
2010-01-01
2015-12-01
Completed
1,069
An Investigational Drug, PF-02341066 Is Being Studied Versus Standard Of Care In Patients With Advanced Non-Small Cell Lung Cancer With A Specific Gene Profile Involving The Anaplastic Lymphoma Kinase (ALK) Gene
2009-09-01
2016-01-01
Completed
347
A Study of Pertuzumab in Addition to Chemotherapy and Trastuzumab as Adjuvant Therapy in Participants With Human Epidermal Growth Receptor 2 (HER2)-Positive Primary Breast Cancer
2011-11-08
2028-11-30
Active, not recruiting
4,804
Study To Evaluate the Efficacy and Safety Of Bevacizumab, and Associated Biomarkers, In Combination With Paclitaxel Compared With Paclitaxel Plus Placebo as First-line Treatment Of Patients With Her2-Negative Metastatic Breast Cancer
2012-08-27
2017-11-21
Completed
481
Phase III Trial BI 695502 Plus Chemotherapy vs. Avastin® Plus Chemotherapy in Patients With Lung Cancer
2015-07-08
2018-11-16
Completed
671
A Study of Taselisib + Fulvestrant Versus Placebo + Fulvestrant in Participants With Advanced or Metastatic Breast Cancer Who Have Disease Recurrence or Progression During or After Aromatase Inhibitor Therapy
2015-04-09
2021-06-29
Terminated
631
A Dose Escalation Study Of PF-06801591 In Melanoma, Head And Neck Cancer (SCCHN), Ovarian, Sarcoma, Non-Small Cell Lung Cancer, Urothelial Carcinoma or Other Solid Tumors
2016-02-10
2020-11-19
Completed
147
Platinum-Based Chemotherapy With/Without INCMGA00012, an Anti-PD-1 Antibody, in Non-Small Cell Lung Cancer
2020-09-27
2025-08-01
Recruiting
600
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "SHATOD 'Dr. Marko Antonov Markov'-Varna, EOOD"
#1 collaborator was "Breast International Group" with 1 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator and "Zai Lab (Shanghai) Co., Ltd." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at SHATOD 'Dr. Marko Antonov Markov'-Varna, EOOD
According to Clinical.Site data, the most researched conditions in "SHATOD 'Dr. Marko Antonov Markov'-Varna, EOOD" are
"Carcinoma, Non-Small-Cell Lung" (3 trials), "Breast Cancer" (2 trials), "Advanced Solid Tumor" (1 trials), "Cervical Cancer" (1 trials) and "Cutaneous Squamous Cell Carcinoma" (1 trials). Many other conditions were trialed in "SHATOD 'Dr. Marko Antonov Markov'-Varna, EOOD" in a lesser frequency.
Clinical Trials Intervention Types at SHATOD 'Dr. Marko Antonov Markov'-Varna, EOOD
Most popular intervention types in "SHATOD 'Dr. Marko Antonov Markov'-Varna, EOOD" are "Drug" (9 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (4 trials), "Paclitaxel" (3 trials), "Carboplatin" (2 trials), "Docetaxel" (2 trials) and "PF-02341066" (2 trials). Other intervention names were less common.
Clinical Trials Genders at SHATOD 'Dr. Marko Antonov Markov'-Varna, EOOD
The vast majority of trials in "SHATOD 'Dr. Marko Antonov Markov'-Varna, EOOD" are
8 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at SHATOD 'Dr. Marko Antonov Markov'-Varna, EOOD
Currently, there are NaN active trials in "SHATOD 'Dr. Marko Antonov Markov'-Varna, EOOD".
undefined are not yet recruiting,
2 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 5 completed trials in SHATOD 'Dr. Marko Antonov Markov'-Varna, EOOD,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in SHATOD 'Dr. Marko Antonov Markov'-Varna, EOOD, 2 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 6 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".